Europe PMCopen access
Dapagliflozin improves hemoglobin and anemia in chronic kidney disease: a systematic review and meta-analysis
Hemoglobin, Erythropoiesis, Chronic Kidney Disease, Dapagliflozin, Anemia Of Chronic Disease, Sodium-glucose Cotransporter 2 Inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 202200
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.